Matches in SemOpenAlex for { <https://semopenalex.org/work/W2938632613> ?p ?o ?g. }
- W2938632613 endingPage "2213" @default.
- W2938632613 startingPage "2199" @default.
- W2938632613 abstract "Tumor targeting agents are being developed for early tumor detection and therapeutics. We previously identified the peptide SNFYMPL (SNF*) and demonstrated its specific binding to human esophageal specimens of high-grade dysplasia (HGD) and adenocarcinoma with imaging ex vivo. Here, we aim to identify the target for this peptide and investigate its potential applications in imaging and drug delivery. With SNF* conjugated affinity chromatography, mass spectrum, Western blot, enzyme-linked immunosorbent assay (ELISA), and molecular docking, we found that the epithelial cell adhesion molecule (EpCAM) was the potential target of SNF*. Next, we showed that FITC-labeled SNF* (SNF*-FITC) colocalized with EpCAM antibody on the surface of esophageal adenocarcinoma cells OE33, and SNF*-FITC binding patterns significantly changed after EpCAM knockdown or exogenous EpCAM transfection. With the data from TCGA, we demonstrated that EpCAM was overexpressed in 17 types of cancers. Using colon and gastric adenocarcinoma cells and tissues as examples, we found that SNF*-FITC bound in a pattern was colocalized with EpCAM antibody, and the SNF* binding did not upregulate the EpCAM downstream Wnt signals. Subsequently, we conjugated SNF* with our previously constructed poly(histidine)-PEG/DSPE copolymer micelles. SNF* labeling significantly improved the micelle binding with colon and gastric adenocarcinoma cells in vitro, and enhanced the antitumor effects and decreased the toxicities of the micelles in vivo. In conclusion, we identified and validated SNF* as a specific peptide for EpCAM. The future potential use of SNF* peptide in multiple tumor surveillance and tumor-targeted therapeutics was demonstrated." @default.
- W2938632613 created "2019-04-25" @default.
- W2938632613 creator A5003782938 @default.
- W2938632613 creator A5006991292 @default.
- W2938632613 creator A5009456882 @default.
- W2938632613 creator A5013378515 @default.
- W2938632613 creator A5020972239 @default.
- W2938632613 creator A5050357869 @default.
- W2938632613 creator A5051126495 @default.
- W2938632613 creator A5051330874 @default.
- W2938632613 creator A5053592727 @default.
- W2938632613 creator A5057943415 @default.
- W2938632613 creator A5059668814 @default.
- W2938632613 creator A5067288072 @default.
- W2938632613 creator A5070585549 @default.
- W2938632613 creator A5074313030 @default.
- W2938632613 creator A5078504833 @default.
- W2938632613 creator A5084257122 @default.
- W2938632613 creator A5087592842 @default.
- W2938632613 date "2019-04-11" @default.
- W2938632613 modified "2023-10-14" @default.
- W2938632613 title "Identification of Tumor Specific Peptide as EpCAM Ligand and Its Potential Diagnostic and Therapeutic Clinical Application" @default.
- W2938632613 cites W1964743637 @default.
- W2938632613 cites W1971307188 @default.
- W2938632613 cites W1979335059 @default.
- W2938632613 cites W1984484474 @default.
- W2938632613 cites W1986978780 @default.
- W2938632613 cites W2010195217 @default.
- W2938632613 cites W2015992294 @default.
- W2938632613 cites W2040605299 @default.
- W2938632613 cites W2061943380 @default.
- W2938632613 cites W2062395662 @default.
- W2938632613 cites W2086016395 @default.
- W2938632613 cites W2089838672 @default.
- W2938632613 cites W2103101557 @default.
- W2938632613 cites W2104233782 @default.
- W2938632613 cites W2114061652 @default.
- W2938632613 cites W2117419667 @default.
- W2938632613 cites W2131986774 @default.
- W2938632613 cites W2132066655 @default.
- W2938632613 cites W2141369960 @default.
- W2938632613 cites W2145542303 @default.
- W2938632613 cites W2154433879 @default.
- W2938632613 cites W2201651739 @default.
- W2938632613 cites W2203014469 @default.
- W2938632613 cites W2512782724 @default.
- W2938632613 cites W2549458217 @default.
- W2938632613 cites W2551998918 @default.
- W2938632613 cites W2566519901 @default.
- W2938632613 cites W2596992411 @default.
- W2938632613 cites W2604279639 @default.
- W2938632613 cites W2605466291 @default.
- W2938632613 cites W2606046137 @default.
- W2938632613 cites W2734394291 @default.
- W2938632613 cites W2742103273 @default.
- W2938632613 cites W2751602375 @default.
- W2938632613 cites W2807465989 @default.
- W2938632613 doi "https://doi.org/10.1021/acs.molpharmaceut.9b00185" @default.
- W2938632613 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30974945" @default.
- W2938632613 hasPublicationYear "2019" @default.
- W2938632613 type Work @default.
- W2938632613 sameAs 2938632613 @default.
- W2938632613 citedByCount "11" @default.
- W2938632613 countsByYear W29386326132020 @default.
- W2938632613 countsByYear W29386326132021 @default.
- W2938632613 countsByYear W29386326132022 @default.
- W2938632613 countsByYear W29386326132023 @default.
- W2938632613 crossrefType "journal-article" @default.
- W2938632613 hasAuthorship W2938632613A5003782938 @default.
- W2938632613 hasAuthorship W2938632613A5006991292 @default.
- W2938632613 hasAuthorship W2938632613A5009456882 @default.
- W2938632613 hasAuthorship W2938632613A5013378515 @default.
- W2938632613 hasAuthorship W2938632613A5020972239 @default.
- W2938632613 hasAuthorship W2938632613A5050357869 @default.
- W2938632613 hasAuthorship W2938632613A5051126495 @default.
- W2938632613 hasAuthorship W2938632613A5051330874 @default.
- W2938632613 hasAuthorship W2938632613A5053592727 @default.
- W2938632613 hasAuthorship W2938632613A5057943415 @default.
- W2938632613 hasAuthorship W2938632613A5059668814 @default.
- W2938632613 hasAuthorship W2938632613A5067288072 @default.
- W2938632613 hasAuthorship W2938632613A5070585549 @default.
- W2938632613 hasAuthorship W2938632613A5074313030 @default.
- W2938632613 hasAuthorship W2938632613A5078504833 @default.
- W2938632613 hasAuthorship W2938632613A5084257122 @default.
- W2938632613 hasAuthorship W2938632613A5087592842 @default.
- W2938632613 hasConcept C1491633281 @default.
- W2938632613 hasConcept C150903083 @default.
- W2938632613 hasConcept C153911025 @default.
- W2938632613 hasConcept C173396325 @default.
- W2938632613 hasConcept C185592680 @default.
- W2938632613 hasConcept C190283241 @default.
- W2938632613 hasConcept C207001950 @default.
- W2938632613 hasConcept C2776677690 @default.
- W2938632613 hasConcept C502942594 @default.
- W2938632613 hasConcept C55493867 @default.
- W2938632613 hasConcept C86803240 @default.
- W2938632613 hasConceptScore W2938632613C1491633281 @default.
- W2938632613 hasConceptScore W2938632613C150903083 @default.